PRCT logo Procept BioRobotics : PRCT

PRCT

Stock Data

$24.63

Change up

$0.59 (2.45%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

MEDICAL DEVICES

Procept BioRobotics Corp is a pioneering force in the field of surgical robotics, specifically targeting urology. With its flagship AquaBeam Robotic System, the company offers a cutting-edge, minimally invasive solution for treating benign prostatic hyperplasia (BPH), a common urological condition. Based in San Jose, California, and established in 2007, Procept BioRobotics is dedicated to improving the quality of life for men experiencing lower urinary tract symptoms through its innovative Aquablation therapy.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.